Besides, USP29 overexpression augments stemness of lung cancer cells after chemotherapy [28] while USP29 knockdown reduces aerobic glycolysis and attenuates Sorafenib resistance in hepatocellular carcinoma cells [29]. Here, USP29 is linked to hepatocellular carcinoma.